United States· US:59390-218_22a50c28-e476-4966-b68c-065a4b8e157f
ALTAFLUOR
A medicinal product containing fluorescein sodium; benoxinate hydrochloride, registered in United States by Altaire Pharmaceuticals Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FLUORESCEIN SODIUM; BENOXINATE HYDROCHLORIDE
- Manufacturer
- Altaire Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1159390218055 mL in 1 BOTTLE, DROPPER (59390-218-05)
- ndc1159390-218-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fluorescein sodium; benoxinate hydrochloride in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandOftan FlurekainSanten Oy
- SpainCOLIROFTA FLUOTEST 2,5 MG/ML + 4 MG/ML COLIRIO EN SOLUCIÓNAlcon Healthcare S.A.
- SwitzerlandFluoresceine Oxybuprocaine SDU Faure, AugentropfenOmniVision AG
- NorwayCombiflureSanten Oy
- SwedenOptax 1,25 mg/ml + 3 mg/ml Ögondroppar, lösningSanten Oy
- GermanyThilorbinOmnivision Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Belgium · Combiflure
- Germany · Thilorbin
- Denmark · Combiflure
- Finland · Oftan Flurekain
- Italy · Flurekain
- Luxembourg · Combiflure, Thilorbin
- Norway · Combiflure
- Portugal · Fluotest Multidose
- Sweden · Optax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4dc03d99-dd74-469b-9386-6961cafbd67b GET /v1/drugs/4dc03d99-dd74-469b-9386-6961cafbd67b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "2.5; 4",
"substance": "FLUORESCEIN SODIUM; BENOXINATE HYDROCHLORIDE",
"productndc": "59390-218",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "NDA208582",
"marketing_category": "NDA"
}See everything about fluorescein sodium; benoxinate hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.